For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
Children who start smoking prior to age 15 have a 27% increased risk of developing chronic obstructive pulmonary disease ( ...